Cataract and Glaucoma Surgery

  • Joseph R. Zelefsky
  • Stephen A. Obstbaum


Cataract and glaucoma are leading causes of worldwide blindness and are among the most common ocular conditions associated with the aging process. Because the worldwide population is aging, the prevalence of cataract and glaucoma are increasing, and these conditions will require greater allocations of resources to achieve favorable outcomes and positive influences on quality-of-life measures. Cataract surgery and intraocular lens (IOL) implantation has become the most successful rehabilitative microsurgical procedure in modern medicine. Our success with the management of glaucoma, either medically or surgically, has not achieved similar success. Nonetheless, we are increasingly forced to deal with situations in which patients have both cataract and glaucoma; and we frequently contend with our patients’ expectations of a functional result similar to that achieved by modern cataract surgery. The perplexing question is how to manage these coexisting conditions to promote the best possible outcome.


Anterior Chamber Cataract Surgery Cystoid Macular Edema Cataract Extraction Visual Field Loss 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Jampel H, Friedman DS, Lubomski LH, et al. Effect of technique on intraocular pressure after combined cataract and glaucoma surgery. Ophthalmology. 2002;109:2215–2224.CrossRefPubMedGoogle Scholar
  2. 2.
    Panchapakesan J, Mitchell P, Tumuluri K, Rochtchina E, Foran S, Cumming RG. Five year incidence of cataract surgery: the Blue Mountains Eye Study. Br J Ophthalmol. 2003;87(2):168–172.CrossRefPubMedGoogle Scholar
  3. 3.
    Krupin T, Feitl ME, Bishop KI. Postoperative intraocular pressure rise in open-angle glaucoma patients after cataract or combined cataract-filtration surgery. Ophthalmology. 1989;96:579–584.PubMedGoogle Scholar
  4. 4.
    Levkovitch-Verbin H, Habot-Wilner Z, Burla N, et al. Intraocular pressure elevation within the first 24 hours after cataract surgery in patients with glaucoma or exfoliation syndrome. Ophthalmology. 2008;115:104–108.CrossRefPubMedGoogle Scholar
  5. 5.
    Pohjalainen T, Vesti E, Uusitalo RJ, et al. Phacoemulsification and intraocular lens implantation in eyes with open-angle glaucoma. Acta Ophthalmol Scand. 2001;79:313–316.CrossRefPubMedGoogle Scholar
  6. 6.
    Brown SV, Thomas JV, Budenz DL, Bellows AR, Simmons RJ. Effect of cataract surgery on intraocular pressure reduction obtained with laser trabeculoplasty. Am J Ophthalmol. 1985;100(3): 373–376.PubMedGoogle Scholar
  7. 7.
    Tennen DG, Masket S. Short and long-term effect of clear corneal incision on intraocular pressure. J Cataract Refract Surg. 1996;22: 568–570.PubMedGoogle Scholar
  8. 8.
    Tong JT, Miller KM. Intraocular pressure change after sutureless phacoemulsification and foldable posterior chamber lens implantation. J Cataract Refract Surg. 1998;24:256–262.PubMedGoogle Scholar
  9. 9.
    Shingleton BJ, Gamell LS, O’Donoghue MW. Long-term changes in intraocular pressure after clear corneal phacoemulsification: normal patients versus glaucoma suspect and glaucoma patients. J Cataract Refract Surg. 1999;25:885–890.CrossRefPubMedGoogle Scholar
  10. 10.
    Shingleton BJ, Pasternak JJ, Hung JW, et al. Three and five year changes in intraocular pressures after clear corneal phacoemulsification in open angle glaucoma patients, glaucoma suspects, and normal patients. J Glaucoma. 2006;15:494–498.CrossRefPubMedGoogle Scholar
  11. 11.
    Kass MA. Cataract extraction in an eye with filtering bleb. Ophthalmology. 1982;89:871–874.PubMedGoogle Scholar
  12. 12.
    Rebolleda G, Muñoz-Negrete FJ. Phacoemulsification in eyes with functioning filtering blebs: a prospective study. Ophthalmology. 2002;109(12):2248–2255.CrossRefPubMedGoogle Scholar
  13. 13.
    Hopkins JJ, Apel A, Trope GE, et al. Early intraocular pressure after phacoemulsification combined with trabeculectomy. Ophthalmic Surg Lasers. 1998;29:273–279.PubMedGoogle Scholar
  14. 14.
    Cotran PR, Roh S, McGwin G. Randomized comparison of 1-site and 2-site phacotrabeculectomy with 3-year follow-up. Ophthalmology. 2008;115:447–454.CrossRefPubMedGoogle Scholar
  15. 15.
    Weitzman M, Caprioli J. Temporal corneal phacoemulsification with separate-incision superior trabeculectomy. Ophthalmic Surg. 1995;26:271–273.PubMedGoogle Scholar
  16. 16.
    Fine IH, Hoffman RS, Packer M. Profile of clear corneal cataract incisions demonstrated by ocular coherence tomography. J Cataract Refract Surg. 2007;33:94–97.CrossRefPubMedGoogle Scholar
  17. 17.
    Bateman DN, Clark R, Azuara-Blanco A, et al. The effects of new topical treatments on management of glaucoma in Scotland: an examination of ophthalmological health care. Br J Ophthalmol. 2002;86:551–554.CrossRefPubMedGoogle Scholar
  18. 18.
    Strutton DR, Walt JG. Trends in glaucoma surgery before and after the introduction of new topical glaucoma pharmacotherapies. J Glaucoma. 2004;13(3):221–226.CrossRefPubMedGoogle Scholar
  19. 19.
    Damji KF, Shah KC, Rock WJ, et al. Selective laser trabeculoplasty v argon laser trabeculoplasty: a prospective randomised clinical trial. Br J Ophthalmol. 1999;83(6):718–722.CrossRefPubMedGoogle Scholar
  20. 20.
    Martinez-de-la-Casa JM, Garcia-Feijoo J, Castillo A, et al. Selective vs argon laser trabeculoplasty: hypotensive efficacy, anterior chamber inflammation, and postoperative pain. Eye. 2004;18(5): 498–502.CrossRefPubMedGoogle Scholar
  21. 21.
    O’Brien TP. Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care. Curr Med Res Opin. 2005;21(7): 1131–1137.CrossRefPubMedGoogle Scholar
  22. 22.
    Oetting TA, Omphroy LC. Modified technique using flexible iris retractors in clear corneal cataract surgery. J Cataract Refract Surg. 2002;28:596–598.CrossRefPubMedGoogle Scholar
  23. 23.
    Akman A, Yilmaz G, Oto S, et al. Comparison of various pupil dilatation methods for phacoemulsification in eyes with a small pupil secondary to pseudoexfoliation. Ophthalmology. 2004;111: 1693–1698.CrossRefPubMedGoogle Scholar
  24. 24.
    Miyake K, Ota I, Maekuba K, et al. Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias. Arch Ophthalmol. 1999;117:34–40.PubMedGoogle Scholar
  25. 25.
    Miyake K, Ota I, Ibaraki N, et al. Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia. Arch Ophthalmol. 2001;119:387–394.PubMedGoogle Scholar
  26. 26.
    Arcieri ES, Santana A, Rocha FN, et al. Blood-aqueous barrier changes after the use of prostaglandin analogues in patients pseudophakia or aphakia. Arch Ophthalmol. 2005;123:186–192.CrossRefPubMedGoogle Scholar


  1. Akhtar RA, Abdel-Latif AA. Surgical sympathetic denervation increases alpha 1-adrenoceptor-mediated accumulation of myo-inositol trisphosphate and muscle contraction in rabbit iris dilator smooth muscle. J Neurochem. 1986;46:96–104.CrossRefPubMedGoogle Scholar
  2. Au L, Wechsler D, Fenerty C. Alpha antagonists and intraoperative floppy iris syndrome (IFIS) during trabeculectomy. Eye. 2007;21:671–6722.PubMedGoogle Scholar
  3. Blouin M, Blouin J, Perreault S, et al. Intraoperative floppy iris syndrome associated with Alpha-1 adrenoreceptors. Comparison of tamsulosin and alfuzosin. J Cataract Refract Surg. 2007;33:1227–1234.CrossRefPubMedGoogle Scholar
  4. Chadha V, Borooah S, Tey A, et al. Floppy iris behaviour during cataract surgery: associations and variations. Br J Ophthalmol. 2007;91:40–42.CrossRefPubMedGoogle Scholar
  5. Chang DF, Braga-Mele R, Mamalis N, et al. Clinical experience with intraoperative floppy-iris syndrome. Results of the 2008 ASCRS member survey. J Cataract Refract Surg. 2008;34:1201–1209.CrossRefPubMedGoogle Scholar
  6. Chang DF, Campbell JR. Intraoperative floppy iris syndrome associated with tamsulosin. J Cataract Refract Surg. 2005;31:664–673.CrossRefPubMedGoogle Scholar
  7. Chang DF, Osher RH, Wang L, Koch DD. A prospective multicenter evaluation of cataract surgery in patients taking tamsulosin (Flomax). Ophthalmology. 2007;114:957–964.CrossRefPubMedGoogle Scholar
  8. Dhingra N, Rajkumar KN, Kumar V. Intraoperative floppy iris syndrome with doxazosin. Eye. 2007;21:678–679.CrossRefPubMedGoogle Scholar
  9. Goepel M, Hecker U, Krege S. Saw palmetto extracts potently and noncompetitively inhibit human alpha1-adrenoceptors in vitro. Prostate.1999;38:208–215.CrossRefPubMedGoogle Scholar
  10. Goseki T, Shimizu K, Ishikawa H, et al. Possible mechanism of intraoperative floppy iris syndrome: a clinicopathological study. Br J Ophthalmol. 2008;92:1156–1158.CrossRefPubMedGoogle Scholar
  11. Gurbaxani A, Packard R. Intracameral phenylephrine to prevent floppy iris syndrome during cataract surgery in patients on tamsulosin. Eye. 2007;21:331–332.CrossRefPubMedGoogle Scholar
  12. Koike T, Kitazumi H, Mukai H. Tissue distribution of NS-49, a phenethylamine class alpha1A-adrenoceptor agonist, in pigmented rates. Arzneimittelforschung. 2001;51:402–407.PubMedGoogle Scholar
  13. Manvikar S, Allen D. Cataract surgery management in patients taking tamsulosin staged approach. J Cataract Refract Surg. 2006; 32:1611–1614.CrossRefPubMedGoogle Scholar
  14. Masket S, Belani S. Combined preoperative topical atropine sulfate 1% and intracameral nonpreserved epinephrine hydrochloride 1:2500 for management of intraoperative floppy-iris syndrome. J Cataract Refract Surg. 2007;33:580–582.CrossRefPubMedGoogle Scholar
  15. Mirza SA, Alexandridou A, Marshall T, et al. Surgically induced miosis during phacoemulsification in patients with diabetes mellitus. Eye. 2003;17:194–199.CrossRefPubMedGoogle Scholar
  16. Norris JH, Mall S, Burnett CAM. Floppy iris syndrome hull hooks (FISH Hooks): a new technique for managing IFIS in trabeculectomy surgery. Eye. 2009;23(3):743–744.CrossRefPubMedGoogle Scholar
  17. Odin L, O’Donnell. Adrenergic influence on iris stromal pigmentation: evidence for alpha-adrenergic receptors. Invest Ophthalmol Vis Sci. 1982;23:528–530.PubMedGoogle Scholar
  18. Oshika T, Ohashi Y, Inamura M, et al. Incidence of intraoperative floppy iris syndrome in patients on either systemic or topical alpha (1)-adrenoceptor antagonist. Am J Ophthalmol. 2007;143:150–151.CrossRefPubMedGoogle Scholar
  19. Palea S, Chang DF, Rekik M, et al. Comparative effect of alfuzosin and tamsulosin on the contractile response of isolated rabbit prostatic and iris dilator smooth muscles. Possible model for intraoperative floppy iris syndrome. J Cataract Refract Surg. 2008;34:489–496.CrossRefPubMedGoogle Scholar
  20. Parssinen O, Leppanen E, Keski-Rahkonen P, Mauriala T, Dugué B, Lehtonen M. Influence of tamsulosin on the iris and its implication for cataract surgery. Invest Ophthalmol Vis Sci. 2006;47:3766–3771.CrossRefPubMedGoogle Scholar
  21. Schwinn DA, Afshari NA. Alpha-1-Adrenergic receptor antagonists and the iris: new mechanistic insights into floppy iris syndrome. Surv Ophthal. 2006;51:501–512.CrossRefGoogle Scholar
  22. Schwinn DA, Roehrborn CG. Alpha-1-Adrenoceptor subtypes and lower urinary tract symptoms. Int J Urol. 2008;15:193–199.CrossRefPubMedGoogle Scholar
  23. Settas G, Fitt AW. Intraoperative floppy iris syndrome in a patient taking alfuzosin for benign prostatic hypertrophy. Eye. 2006;20:1431–1432.CrossRefPubMedGoogle Scholar
  24. Smith SA, Smith SE. Evidence for a neuropathic etiology in the small pupil of diabetes mellitus. Br J Ophthalmol. 1983;67:89–93.CrossRefPubMedGoogle Scholar
  25. Suzuki F, Taniguchi T, Nakamura S, et al. Distribution of alpha-1 adrenoceptor subtypes in RNA and protein in rabbit eyes. Br J Pharmacol. 2002;135:600–608.CrossRefPubMedGoogle Scholar
  26. Takmaz T, Can I. Clinical features, complications, and incidence of intraoperative floppy iris syndrome in patients taking tamsulosin. Eur J Ophthalmol. 2007;6:909–913.Google Scholar
  27. Venkatesh R, Veena K, Gupta S, Ravindran RD. Intraoperative floppy iris syndrome associated with terazosin. Indian J ophthalmol. 2007;55:395–396.CrossRefPubMedGoogle Scholar
  28. Wenzel RR, Ruthemann J, Bruck H, et al. Endothelin-A receptor antagonist inhibits angiotensin II and noradrenaline in man. Br J Clin Pharmacol. 2001;52:151–157.CrossRefPubMedGoogle Scholar
  29. Wollensak G, Schaefer HE, Ihling C. An immunohistochemical study of endothelin-1 in the human eye. Curr Eye Res. 1998;17: 541–545.CrossRefPubMedGoogle Scholar
  30. Yamada T, Okuyama Y, Mukai H. In vitro melanin binding of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. Arzneimittelforschung. 2001;51:299–303.PubMedGoogle Scholar
  31. Yeu E, Grostern R. Saw palmetto and intraoperative floppy-iris syndrome. J Cataract Refract Surg. 2007;33:927–928.CrossRefPubMedGoogle Scholar
  32. Yu Y, Koss MC. Studies of alpha-adrenoceptor antagonists on sympathetic mydriasis in rabbits. J Ocul Pharmacol Ther. 2003;19: 255–263.CrossRefPubMedGoogle Scholar
  33. Zaczek A, Zetterstrom C. Cataract surgery and pupil size in patients with diabetes mellitus. Acta Ophthalmol Scand. 1997;75:429–432.CrossRefPubMedGoogle Scholar
  34. Ziada A, Rosenblum M, Crawford ED. Benign prostatic hyperplasia: an overview. Urology. 1999;53:1–6.CrossRefPubMedGoogle Scholar
  35. Chandler PA. Glaucoma from pupillary block in aphakia. Trans Am Ophthalmol Soc. 1961;59:96–105.PubMedGoogle Scholar
  36. Gaton DD, Mimouni K, Lusky M, et al. Pupillary block following posterior chamber intraocular lens implantation in adults. Br J Opthalmol. 2003;87:1109–1111.CrossRefGoogle Scholar
  37. Kalina PH, Shingleton BJ. Glaucoma after cataract surgery. In. Steinert, R, ed. Cataract Surgery: Technique, Complications, and Management. 2nd ed. Philadelphia, PA: Elselvier; 2004:515.Google Scholar
  38. Melamed S. Recurrent closure of neodymium: YAG laser iridotomies requiring multiple treatments in pseudophakic pupillary block. Ann Ophthalmol. 1988;20:105–108.PubMedGoogle Scholar
  39. Van Buskirk EM. Pupillary block after intraocular lens implantation, Am J Ophthalmol. 1983;95:55–59PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Joseph R. Zelefsky
    • 1
  • Stephen A. Obstbaum
    • 2
    • 3
  1. 1.Department of OphthalmologyNew York UniversityNew YorkUSA
  2. 2.NYU School of MedicineNew YorkUSA
  3. 3.Department of OphthalmologyLenox Hill HospitalNew YorkUSA

Personalised recommendations